SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001753926-24-000729
Filing Date
2024-04-15
Accepted
2024-04-12 19:22:17
Documents
9
Effectiveness Date
2024-04-15

Document Format Files

Seq Description Document Type Size
1 S-8 g084174_s8.htm S-8 60322
2 EXHIBIT 4.4 g084174_ex4-4.htm EX-4.4 3567
3 EXHIBIT 4.5 g084174_ex4-5.htm EX-4.5 49666
4 EXHIBIT 4.6 g084174_ex4-6.htm EX-4.6 47359
5 EXHIBIT 5.1 g084174_ex5-1.htm EX-5.1 9366
6 EXHIBIT 23.1 g084174_ex23-1.htm EX-23.1 4633
7 EXHIBIT 107 g084174_ex107.htm EX-FILING FEES 14550
8 GRAPHIC img001_v1.jpg GRAPHIC 11767
9 GRAPHIC img002_v1.jpg GRAPHIC 3234
  Complete submission text file 0001753926-24-000729.txt   211446
Mailing Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902
Business Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902 9176446313
Chromocell Therapeutics Corp (Filer) CIK: 0001919246 (see all company filings)

IRS No.: 863335449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278674 | Film No.: 24842819
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)